CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.

The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...

Researchers at The Institute of Cancer Research, London identified the CIP2A–TOPBP1 complex as a master regulator of DNA ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

A new advanced gene therapy for patients with beta-thalassemia is underway at Brotzu: the goal is to eliminate transfusions. The therapy, recently recognized at the European and national levels, uses ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

A woman who has undergone a pioneering gene-editing treatment on the NHS is optimistic that 2026 will mark the year she is cured of a severe blood disorder. Kavita Mehta, 36, from London, suffers from ...

Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in 2026. When you purchase through links on our site, we may earn an affiliate ...

If you are wondering whether Bristol-Myers Squibb is priced attractively right now, you are not alone. This article walks ...